Odysight.ai Inc. announced that Mr. Nir Nimrodi has been appointed to its board of directors. Mr. Nimrodi is currently the Chairman and Chief Executive Officer of Accellix Inc., a growth stage company focused on enabling cell and gene therapy companies to meet their key product QC requirements by providing fast and actionable multi-parametric results. Mr. Nimrodi brings more than 25 years of global leadership experience.

Prior to Accellix, Mr. Nimrodi served as Chief Business Officer at Intrexon (currently Precigen Inc.), and was Vice President and General Manager at Life Technologies (now part of Thermo Fisher), where he took part in the company?s rapid growth from $1.2 to $3.8 billion in revenues during that time. Mr. Nimrodi studied at Tel-Aviv University and holds an MBA, focusing on Finance and Economics.